go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Indiana rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$2,2390%50%90th$0Professionalmedian $3,236 · 10th–90th $2,239$4,1690%20%10th90th$3,236$0.0$0.2$2.0$20.0$200.0$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$3,235.94
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,344.23
Median
$3,235.94
Typical High
$3,388.44
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.03
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$2,238.72
Median
$2,691.53
Typical High
$4,168.69
Cigna
Setting
Facility
Modifier
Global
Typical Low
$5,011.87
Median
$9,549.93
Typical High
$9,549.93
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Facility
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$6,760.83
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$6,309.57